2025
|
Invention
|
Cell-free method of producing synthetic circular nucleic acid.
The present disclosure relates to... |
|
G/S
|
Reagents for use in genetic research; Reagents for scientific or medical research use; Biochemica... |
2024
|
Invention
|
Gene therapy vectors and methods of production and use thereof. Provided herein are improved DNA ... |
|
Invention
|
Synthetic dna vectors and methods of use.
Provided herein are isolated DNA vectors comprising a ... |
|
Invention
|
Quantification of free guide rna in crispr complexes. The present invention relates to a novel an... |
|
Invention
|
Gene therapies for the front of the eye. The present invention involves therapies for ocular dise... |
2023
|
Invention
|
Replicative minicircle vectors with improved expression.
A eukaryotic replicative pUC-free minic... |
|
Invention
|
Devices and methods for electrotransfer.
Provided herein are electrotransfer devices for deliver... |
|
Invention
|
Chromatography column stand. A chromatography column stand includes a floor portion, a wall porti... |
|
Invention
|
Best1 vectors and uses thereof. Provided herein are expression constructs, nucleic acid vectors, ... |
|
Invention
|
Cell-free method of producing synthetic circular nucleic acid |
|
Invention
|
Cell-free method of producing synthetic circular nucleic acid. The present disclosure relates to ... |
|
Invention
|
Methods for producing cyclic dinucleotides. The present disclosure provides a method of producing... |
|
Invention
|
Muscle-specific hybrid promoter.
The present disclosure provides novel combinations of muscle-sp... |
2022
|
Invention
|
Devices and methods for hollow tissue electrotransfer.
The invention provides devices and system... |
|
Invention
|
Production of gene therapy vector in engineered bacteria.
Provided herein are improved methods o... |
|
Invention
|
Dna plasmids with improved expression.
The present invention relates to the production and use o... |
|
Invention
|
Synthetic dna vectors and methods of use. Provided herein are isolated DNA vectors comprising a h... |
|
Invention
|
Respiratory delivery of therapeutic agents.
Provided herein are methods of delivering therapeuti... |
|
Invention
|
Respiratory delivery of therapeutic agents. Provided herein are methods of delivering therapeutic... |
|
Invention
|
Synthetic production of circular dna vectors.
Provided herein are improved methods of producing ... |
|
Invention
|
Synthetic production of circular dna vectors. Provided herein are improved methods of producing t... |
|
G/S
|
Biological substances, namely, microorganisms engineered for plasmid DNA manufacturing. |
|
G/S
|
Biological substances, materials, and preparations for manufacture and development of gene therap... |
|
G/S
|
Biological substances, namely, cellular growth media for use in plasmid DNA manufacturing platfor... |
|
G/S
|
Plasmid DNA manufacturing platform; biological processes for plasmid DNA manufacturing using biol... |
|
G/S
|
Biological substances, namely, microorganisms engineered for plasmid DNA manufacturing |
|
Invention
|
Bacterial host strains.
The present disclosure provides engineered E. coli host cells that combi... |
|
G/S
|
Enzymes in the nature of nucleases and nuclease panels for scientific and research purposes; enzy... |
|
G/S
|
DNA-modifying endonucleases and nucleic acid vectors for scientific and research purposes, namely... |
|
Invention
|
Ocular delivery of therapeutic agents.
The present invention involves devices and therapies for ... |
|
Invention
|
Ocular delivery of therapeutic agents. The present invention involves devices and therapies for o... |
|
Invention
|
Nucleic acid vectors and methods of use.
The present invention involves nucleic acid vectors (e.... |
|
G/S
|
Biological preparations for use in industry and science, namely, for manufacture and development ... |
|
G/S
|
Biological preparations for use in industry and science, namely culture medium for plasmid DNA ma... |
|
G/S
|
Biological preparations for industry and science, namely, microorganisms engineered for plasmid D... |
|
G/S
|
nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels... |
|
G/S
|
Enzymes in the nature of nucleases and nuclease panels for scientific and research purposes; Enzy... |
2021
|
G/S
|
Biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodi... |
|
Invention
|
Potent and selective inhibitors of nav1.7.
The present disclosure relates to a peptide and its a... |
|
Invention
|
Potent and selective inhibitors of nav1.7. The present disclosure relates to a peptide and its an... |
|
Invention
|
Muscle-specific hybrid promoter. The present disclosure provides novel combinations of muscle-spe... |
|
Invention
|
Bacterial host strains. The present disclosure provides engineered E. coli host cells that combin... |
|
Invention
|
Growth of bacterial host cells in gas permeable low-density polyethylene bags for production of p... |
2020
|
Invention
|
Dna plasmids with improved expression. The present invention relates to the production and use of... |
|
Invention
|
Replicative minicircle vectors with improved expression. A eukaryotic replicative pUC-free minici... |
|
Invention
|
Viral and non-viral nanoplasmid vectors with improved production.
A method for improving the rep... |
|
Invention
|
Growing bacterial host cells in gas-permeable low-density polyethylene bags to produce plasmid dn... |
2019
|
Invention
|
Viral and non-viral nanoplasmid vectors with improved production. A method for improving the repl... |
2018
|
Invention
|
Replicative minicircle vectors with improved expression. The present invention relates to the pro... |
2017
|
G/S
|
Manufacturing services for others in the field of biologics for research, clinical and diagnostic... |
|
G/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
G/S
|
Biologics, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies ... |
2016
|
G/S
|
Manufacturing services for others in the field of biologics for research, clinical, and diagnosti... |
2015
|
Invention
|
Vectors and methods for genetic immunization. Improved DNA vaccine plasmids are disclosed that co... |
|
Invention
|
E. coli plasmid dna production. General methods and strains of bacteria are described that dramat... |
2011
|
G/S
|
Contract manufacturing in the field of biologics for research, clinical, and diagnostic applicati... |